Overview

  • Product nameAnti-LOX 1 antibody
    See all LOX 1 primary antibodies
  • Description
    Rabbit polyclonal to LOX 1
  • Tested applicationsSuitable for: IHC-P, ICC/IF, WBmore details
  • Species reactivity
    Reacts with: Mouse, Rat, Human, Pig
  • Immunogen

    Synthetic peptide near the N-terminus of human Lox-1

  • Positive control
    • Jurkat cell lysate

Properties

Applications

Our Abpromise guarantee covers the use of ab60178 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IHC-P Use at an assay dependent concentration.
ICC/IF Use a concentration of 5 µg/ml.
WB Use a concentration of 0.5 - 4 µg/ml. Predicted molecular weight: 31 kDa.Can be blocked with LOX 1 peptide (ab183565). Proform detected at 50 kDa, mature form detected at 31 kDa.

Target

  • FunctionReceptor that mediates the recognition, internalization and degradation of oxidatively modified low density lipoprotein (oxLDL) by vascular endothelial cells. OxLDL is a marker of atherosclerosis that induces vascular endothelial cell activation and dysfunction, resulting in pro-inflammatory responses, pro-oxidative conditions and apoptosis. Its association with oxLDL induces the activation of NF-kappa-B through an increased production of intracellular reactive oxygen and a variety of pro-atherogenic cellular responses including a reduction of nitric oxide (NO) release, monocyte adhesion and apoptosis. In addition to binding oxLDL, it acts as a receptor for the HSP70 protein involved in antigen cross-presentation to naive T-cells in dendritic cells, thereby participating in cell-mediated antigen cross-presentation. Also involved in inflammatory process, by acting as a leukocyte-adhesion molecule at the vascular interface in endotoxin-induced inflammation. Also acts as a receptor for advanced glycation end (AGE) products, activated platelets, monocytes, apoptotic cells and both Gram-negative and Gram-positive bacteria.
  • Tissue specificityExpressed at high level in endothelial cells and vascular-rich organs such as placenta, lung, liver and brain, aortic intima, bone marrow, spinal cord and substantia nigra. Also expressed at the surface of dendritic cells. Widely expressed at intermediate and low level.
  • Involvement in diseaseNote=Independent association genetic studies have implicated OLR1 gene variants in myocardial infarction susceptibility.
    Note=OLR1 may be involved in Alzheimer disease (AD). Involvement in AD is however unclear: according to some authors (PubMed:12354387, PubMed:12810610 and PubMed:15976314), variations in OLR1 modify the risk of AD, while according to other (PubMed:15000751 and PubMed:15060104) they do not.
  • Sequence similaritiesContains 1 C-type lectin domain.
  • DomainThe cytoplasmic region is required for subcellular sorting on the cell surface.
    The C-type lectin domain mediates the recognition and binding of oxLDL.
  • Post-translational
    modifications
    The intrachain disulfide-bonds prevent N-glycosylation at some sites.
    N-glycosylated.
  • Cellular localizationCell membrane. Secreted. A secreted form also exists.
  • Information by UniProt
  • Database links
  • Alternative names
    • C-type lectin domain family 8 member A antibody
    • CLEC8A antibody
    • hLOX 1 antibody
    • hLOX-1 antibody
    • Lectin like oxidized LDL receptor 1 antibody
    • Lectin like oxLDL receptor 1 antibody
    • Lectin type oxidized LDL receptor 1 antibody
    • Lectin-like oxidized LDL receptor 1 antibody
    • Lectin-like oxLDL receptor 1 antibody
    • Lectin-type oxidized LDL receptor 1 antibody
    • low density lipoprotein oxidized, receptor 1 antibody
    • LOX-1 antibody
    • LOXIN antibody
    • Olr1 antibody
    • OLR1_HUMAN antibody
    • Ox LDL receptor 1 antibody
    • Ox-LDL receptor 1 antibody
    • Oxidised low density lipoprotein (lectin like) receptor 1 antibody
    • Oxidized low density lipoprotein receptor 1 antibody
    • Oxidized low density lipoprotein receptor 1 soluble form antibody
    • Oxidized low-density lipoprotein receptor 1 antibody
    • SCARE1 antibody
    • Scavenger receptor class E, member 1 antibody
    • SLOX1 antibody
    • soluble form antibody
    • SR-EI antibody
    see all

Anti-LOX 1 antibody images

  • All lanes : Anti-LOX 1 antibody (ab60178) at 0.5 µg/ml

    Lane 1 : Jurkat cell lysate
    Lane 2 : Jurkat cell lysate


    Predicted band size : 31 kDa
    Observed band size : 31,50 kDa (why is the actual band size different from the predicted?)
  • ICC/IF image of ab60178 stained HeLa cells. The cells were 4% formaldehyde (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab60178, 5µg/ml) overnight at +4°C. The secondary antibody (green) was for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

  • ab60178 staining LOX 1 in mouse heart and carotid artery tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections). Tissue was fixed with 10% formalin and blocked with 10% BSA for 1 hour at room temperature; antigen retrieval was by heat mediation. Samples were incubated with primary antibody (1/100) for 12 hours at 4°C. An Alexa Fluor® 647-conjugated goat anti-rabbit IgG monoclonal (1/1000) was used as the secondary antibody. Counter stained with DAPI.

    See Abreview

References for Anti-LOX 1 antibody (ab60178)

This product has been referenced in:
  • Rosa CM  et al. Apocynin influence on oxidative stress and cardiac remodeling of spontaneously hypertensive rats with diabetes mellitus. Cardiovasc Diabetol 15:126 (2016). WB . Read more (PubMed: 27585437) »
  • Wang XQ  et al. CLI-095 decreases atherosclerosis by modulating foam cell formation in apolipoprotein E-deficient mice. Mol Med Rep 14:49-56 (2016). Read more (PubMed: 27176130) »

See all 11 Publications for this product

Product Wall

Thank you for your enquiry regarding ab60178.

I regret to inform you that we do not have blocking peptide available for this particular antibody. ab60178 has been tested on ICC/IF (immunocytochemistry) but not on formalin-fixed paraffin embed...

Read More
Application Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)
Sample Mouse Tissue sections (heart and carotid artery)
Antigen retrieval step Heat mediated - Buffer/Enzyme Used: Antigen Retrieval sol. H-3300 Vector lab
Permeabilization No
Specification heart and carotid artery
Blocking step BSA as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 10% · Temperature: RT°C
Fixative formalin 10% buffered neutral
Username

Abcam user community

Verified customer

Submitted Oct 21 2014

Application Western blot
Loading amount 20 µg
Gel Running Conditions Reduced Denaturing (10)
Sample Rat Tissue lysate - whole (Thoracic Aorta Tissue Homogenate)
Specification Thoracic Aorta Tissue Homogenate
Blocking step Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 25°C
Username

Abcam user community

Verified customer

Submitted Jan 29 2014

Thank you for your call.

Unfortunately, I have to confirm that the antibodies we have in our catalog are unlikely to definitively not react with pig.

The whole protein shows ca 70% homology between human and pig. Therefore we would ...

Read More

Thank you for contacting us.

I agree, the blurry banding above the proform is likely caused by glycosylations and that the other major band at 31 kDa is the mature form of LOX 1. According to the following reference, the soluble form of LOX1 ...

Read More

Thank you for your enquiry. Here are answers to your questions: Q1: Can I have the URL for the EasyLink informational page? A1: http://www.abcam.com/easylink Q2: What is the email address of the person responsible for bulk order requests at Abcam? A2: ...

Read More
Abcam guarantees this product to work in the species/application used in this Abreview.
Application Western blot
Sample Human Cell lysate - whole cell (human embryonic kidney cells (293T))
Loading amount 20 µg
Specification human embryonic kidney cells (293T)
Treatment transfected with 300ng of plasmid expressing porcine LOX-1 cDNA (NM 213805)
Gel Running Conditions Reduced Denaturing (4-15%)
Blocking step Milk as blocking agent for 2 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 25°C
Username

Abcam user community

Verified customer

Submitted Feb 19 2010

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"